Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid Carcinoma
Open Access
- 3 May 2000
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 283 (17) , 2272-2274
- https://doi.org/10.1001/jama.283.17.2272
Abstract
In May 1997, the US Nuclear Regulatory Commission revised its patient release regulations.1 Under the previous rule, patients receiving sodium iodide 131I therapy could not be released from medical confinement until the exposure rate was less than 12.9 × 10−7C/kg/h (5 mR/h) at a distance of 1 m from the patient or until the patient's radionuclide activity was less than 1.1 GBq. Accordingly, patients treated with large doses of 131I for thyroid cancer typically were hospitalized under virtual isolation conditions for up to several days after treatment.Keywords
This publication has 1 reference indexed in Scilit:
- Contamination of the home environment by patients treated with Iodine-131: initial results.American Journal of Public Health, 1978